PTBP1抗体

+ +

•  

   

     Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane 1-2: A549 and HepG2 cell lysates, Primary antibody: P09768(PTBP1 Antibody) at dilution 1/1000, Secondary antibody: Goat anti rabbit IgG at 1/5000 dilution, Exposure time: 30 seconds    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human colorectal cancer tissue using P09768(PTBP1 Antibody) at dilution 1/70. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human breast cancer tissue using P09768(PTBP1 Antibody) at dilution 1/70. (Original magnification: ×200)    

  
  

**Background of PTBP1 Antibody**

PTBP1 (Polypyrimidine Tract-Binding Protein 1), also known as hnRNP I, is an RNA-binding protein involved in regulating RNA processing, including splicing, stability, and translation. It contains four RNA recognition motifs (RRMs) that bind pyrimidine-rich sequences in pre-mRNAs, influencing alternative splicing decisions. PTBP1 is ubiquitously expressed but shows dynamic regulation during development, particularly in the nervous system, where its downregulation is critical for neuronal differentiation.

PTBP1 antibodies are essential tools for studying its roles in RNA metabolism and cellular processes. They are widely used in techniques like Western blotting, immunofluorescence, and RNA immunoprecipitation (RIP) to detect PTBP1 expression, localization, and RNA interactions. These antibodies help elucidate PTBP1's involvement in diseases, including cancer, where its overexpression correlates with tumor progression and metastasis, and neurodegenerative disorders, where dysregulated splicing may contribute to pathogenesis.

Many PTBP1 antibodies target specific epitopes, such as the N-terminal or RRM domains, and their specificity is validated using knockout controls. Cross-reactivity with paralogs (e.g., PTBP2/PTBP3) is a consideration, requiring careful antibody selection. Research using PTBP1 antibodies continues to uncover its regulatory networks, therapeutic potential, and interactions with non-coding RNAs or viral RNAs, highlighting its multifaceted role in gene expression.